Show me where i was ever wrong about anything. Even once.
If only i had tomorrow's newspaper to make pick's on games today, lol.
Thankfully you were not our leader. Things would be so much worse!
Sure, ignore those who are suffering & dying. Do they even matter to you.
Way over a million dead in months & counting. Would be well beyond 10 million fatalities without extreme safety measures.
"Hilarious how asssniffer Pence tried to take credit for this vaccine and Pfizer quickly tweeted back and put him in his place basically calling him a lying asslicking POS. LMAO"
"“Based on current projections we expect to produce globally up to 50 million vaccine doses in 2020..."
https://globalnews.ca/news/7450985/pfizer-coronavirus-vaccine-trials-caution-experts/
So no where near enough to vaccinate even the USA, let alone the planet, next year.
With that vaccine each person requires 2 doses.
"“Based on current projections we expect to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses in 2021,” the company said (enough to vaccinate 650 million people as it is a double dose)."
No doubt at least 25 million will want it which is the number of people projected to get it next year globally. Even if all 25 million were in the USA that is only a small percentage of the population. So this vaccine is not going to do diddly squat for the world wide epidemic next year. Assuming it is even effective, which is far from a lock at this point (read the entire article i posted a link to).
With vaccines such as this it is recommended generally that everyone needs to & should get it. Since even healthy people can pass the virus from an infection to those who are at "high risk" re serious issues and or death from C-19.
Furthermore just because a person has "had it", i.e. been infected, does not guarantee they can't "have it" again & have serious problems the second time.
"This story reminds me about how scientifically illiterate the media combined with a love of explosive headlines.
The problem is this is a statistical analysis, not a serological one.
The details.
39,000 people in their study have received the two doses, some the vaccine and some placebo.
Of those participants, they so far studied the first 94 people who were symptomatic (asymptomatic people were not tested)
Of those 94, it seems 85 or so were from the placebo group.
From what I understand, no participants were purposefully exposed to the virus 9an ethiocs no-no) so those infected would be from community transmission and this adds a significant extraneous variable into the data.
The correct headline would be "Of the symptomatic participants in Pfizer's study, only 10% were from the vaccine group". That's not exciting enough to draw clicks and doesn't help Pfizer increase its market share of vaccine pre-orders.
I'm still hopeful but the headline is more than a tad misleading."
"Normal life back next winter, says vaccine creator
The impact of a new Covid vaccine will kick in significantly over summer and life should be back to normal by next winter, one of its creators has said.
Prof Ugur Sahin, BioNTech co-founder, also raised hopes the jab could halve transmission of the virus, resulting in a "dramatic reduction in cases".
Last week, BioNTech and co-developers Pfizer said preliminary analysis showed their vaccine could prevent more than 90% of people from getting Covid-19.
...In an interview on BBC One's Andrew Marr Show, Prof Sahin said he expected further analysis to show the vaccine would reduce transmission between people as well as stop symptoms developing in someone who has had the vaccine.
"I'm very confident that transmission between people will be reduced by such a highly effective vaccine - maybe not 90% but maybe 50% - but we should not forget that even that could result in a dramatic reduction of the pandemic spread," he said.
The UK is expected to get 10 million doses of the BioNTech/Pfizer vaccine by the end of the year, with a further 30 million doses already ordered. The jab, which was trialled in six countries, is given in two doses, three weeks apart.
Older residents and staff in care homes are likely to be prioritised, followed by health workers and the over-80s. People would then be ranked by age.
After the announcement of the world's first effective vaccine came on Monday, Sir John Bell, regius professor of medicine at Oxford University, suggested life could be back to normal by spring.
"I am probably the first guy to say that, but I will say that with some confidence," he said.
However, Prof Sahin said it would take longer.
If everything continued to go well, he said, the vaccine would begin to be delivered at the "end of this year, beginning of next year".
He said the goal was to deliver more than 300 million doses worldwide by next April, which "could allow us to only start to make an impact".
He said the bigger impact would happen later, adding: "Summer will help us because the infection rate will go down in the summer and what is absolutely essential is that we get a high vaccination rate until or before autumn/winter next year."
Prof Sahin said it was essential that all immunisation programmes were completed before next autumn.
The vaccine has given a boost of confidence that an end to the pandemic is close, with the leading scientist behind it hopeful life could return to normal by next winter.
But there are some big uncertainties.
The vaccine has given a boost of confidence that an end to the pandemic is close, with the leading scientist behind it hopeful life could return to normal by next winter.
But there are some big uncertainties.
The vaccine needs approval from regulators - and they will only grant that if they're happy the jab is safe and works well. Early results look very good, but we await the full ones in the coming weeks.
There is also no data yet to show how well the jab works in those who need it the most - the elderly.
Nor do we know if it stops people spreading the disease, as well as getting sick.
And it's not clear how long immunity might last. People might need yearly boosters.
If the vaccine is rolled out, it will take time to immunise and protect enough people.
Other Covid-19 vaccines may come along that work just as well or even better than this new vaccine.
But it is possible that by the summer, mass immunisation will be well under way and we could start to reap the benefits.
Asked if the vaccine was as effective in older people as it is in younger people, he said he expected to have a better idea in the next three weeks.
He said it was not yet known how long immunity would last after the second dose of the vaccine is given.
However, he said, a booster immunisation "should not be too complicated" if it was found immunity was reduced significantly after one year.
Prof Sahin also said the "key side effects" of the vaccine seen so far were a mild to moderate pain in the injection site for a few days, while some participants had a mild to moderate fever over a similar period.
"We did not see any other serious side effects which would result in pausing or halting of the study," he added.
His vaccine is one of 11 currently in the final stages of testing.
It will not be released for use in the UK until it passes final safety tests and gets the go-ahead from the Medicines and Healthcare products Regulatory Agency (MHRA). The agency's head has said it would not lower its safety standards despite the need to get a vaccine quickly.
If it was approved, the NHS would be ready to roll out the vaccine from December, Health Secretary Matt Hancock said.
Prime Minister Boris Johnson has urged people not to slacken their resolve in the meantime, saying the vaccine's development "cleared one significant hurdle but there are several more to go".
Meanwhile, concerns have been raised that mutated forms of the virus might hamper the effectiveness of future vaccines.
It comes after 12 people were found with a mink-related strain of the virus following an outbreak in Denmark.
Virology professor Wendy Barclay, a scientific adviser for the government, said there was a "worry" that the vaccines currently under development "won't work quite so well as the virus continues to evolve".
This did not mean vaccines would not work at all, she added, but adaptable and fast-responding jabs could be the best option.
Earlier, Labour accused the government of not doing enough to "stamp out dangerous" anti-vaccine content online and called for emergency laws brought in.
It wants financial and criminal penalties for social media firms that do not remove false scare stories about vaccines.
Shadow health secretary Jonathan Ashworth said such content was "exploiting people's fears, their mistrust of institutions and governments and spreading poison and harm".
His party wanted to work with the government on a cross-party basis to build trust and help promote take-up of the vaccine, he said.
The government said it took the issue "extremely seriously" with "a major commitment" from Facebook, Twitter and Google to tackle anti-vaccine content.
Many social media platforms label false content as misleading or disputed - and all remove posts that contravene terms of service.
https://www.bbc.com/news/health-54949799
The impact of a new Covid vaccine will kick in significantly over summer and life should be back to normal by next winter, one of its creators has said.
Prof Ugur Sahin, BioNTech co-founder, also raised hopes the jab could halve transmission of the virus, resulting in a "dramatic reduction in cases".
Last week, BioNTech and co-developers Pfizer said preliminary analysis showed their vaccine could prevent more than 90% of people from getting Covid-19.
...In an interview on BBC One's Andrew Marr Show, Prof Sahin said he expected further analysis to show the vaccine would reduce transmission between people as well as stop symptoms developing in someone who has had the vaccine.
"I'm very confident that transmission between people will be reduced by such a highly effective vaccine - maybe not 90% but maybe 50% - but we should not forget that even that could result in a dramatic reduction of the pandemic spread," he said.
The UK is expected to get 10 million doses of the BioNTech/Pfizer vaccine by the end of the year, with a further 30 million doses already ordered. The jab, which was trialled in six countries, is given in two doses, three weeks apart.
Older residents and staff in care homes are likely to be prioritised, followed by health workers and the over-80s. People would then be ranked by age.
After the announcement of the world's first effective vaccine came on Monday, Sir John Bell, regius professor of medicine at Oxford University, suggested life could be back to normal by spring.
"I am probably the first guy to say that, but I will say that with some confidence," he said.
However, Prof Sahin said it would take longer.
If everything continued to go well, he said, the vaccine would begin to be delivered at the "end of this year, beginning of next year".
He said the goal was to deliver more than 300 million doses worldwide by next April, which "could allow us to only start to make an impact".
He said the bigger impact would happen later, adding: "Summer will help us because the infection rate will go down in the summer and what is absolutely essential is that we get a high vaccination rate until or before autumn/winter next year."
Prof Sahin said it was essential that all immunisation programmes were completed before next autumn.
The vaccine has given a boost of confidence that an end to the pandemic is close, with the leading scientist behind it hopeful life could return to normal by next winter.
But there are some big uncertainties.
The vaccine has given a boost of confidence that an end to the pandemic is close, with the leading scientist behind it hopeful life could return to normal by next winter.
But there are some big uncertainties.
The vaccine needs approval from regulators - and they will only grant that if they're happy the jab is safe and works well. Early results look very good, but we await the full ones in the coming weeks.
There is also no data yet to show how well the jab works in those who need it the most - the elderly.
Nor do we know if it stops people spreading the disease, as well as getting sick.
And it's not clear how long immunity might last. People might need yearly boosters.
If the vaccine is rolled out, it will take time to immunise and protect enough people.
Other Covid-19 vaccines may come along that work just as well or even better than this new vaccine.
But it is possible that by the summer, mass immunisation will be well under way and we could start to reap the benefits.
Asked if the vaccine was as effective in older people as it is in younger people, he said he expected to have a better idea in the next three weeks.
He said it was not yet known how long immunity would last after the second dose of the vaccine is given.
However, he said, a booster immunisation "should not be too complicated" if it was found immunity was reduced significantly after one year.
Prof Sahin also said the "key side effects" of the vaccine seen so far were a mild to moderate pain in the injection site for a few days, while some participants had a mild to moderate fever over a similar period.
"We did not see any other serious side effects which would result in pausing or halting of the study," he added.
His vaccine is one of 11 currently in the final stages of testing.
It will not be released for use in the UK until it passes final safety tests and gets the go-ahead from the Medicines and Healthcare products Regulatory Agency (MHRA). The agency's head has said it would not lower its safety standards despite the need to get a vaccine quickly.
If it was approved, the NHS would be ready to roll out the vaccine from December, Health Secretary Matt Hancock said.
Prime Minister Boris Johnson has urged people not to slacken their resolve in the meantime, saying the vaccine's development "cleared one significant hurdle but there are several more to go".
Meanwhile, concerns have been raised that mutated forms of the virus might hamper the effectiveness of future vaccines.
It comes after 12 people were found with a mink-related strain of the virus following an outbreak in Denmark.
Virology professor Wendy Barclay, a scientific adviser for the government, said there was a "worry" that the vaccines currently under development "won't work quite so well as the virus continues to evolve".
This did not mean vaccines would not work at all, she added, but adaptable and fast-responding jabs could be the best option.
Earlier, Labour accused the government of not doing enough to "stamp out dangerous" anti-vaccine content online and called for emergency laws brought in.
It wants financial and criminal penalties for social media firms that do not remove false scare stories about vaccines.
Shadow health secretary Jonathan Ashworth said such content was "exploiting people's fears, their mistrust of institutions and governments and spreading poison and harm".
His party wanted to work with the government on a cross-party basis to build trust and help promote take-up of the vaccine, he said.
The government said it took the issue "extremely seriously" with "a major commitment" from Facebook, Twitter and Google to tackle anti-vaccine content.
Many social media platforms label false content as misleading or disputed - and all remove posts that contravene terms of service.
https://www.bbc.com/news/health-54949799
"Oxford University vaccine is highly effective
The coronavirus vaccine developed by the University of Oxford is highly effective at stopping people developing Covid-19 symptoms, a large trial shows.
Interim data suggests 70% protection, but the researchers say the figure may be as high as 90% by tweaking the dose.
The results will be seen as a triumph, but come after Pfizer and Moderna vaccines showed 95% protection.
However, the Oxford jab is far cheaper, and is easier to store and get to every corner of the world than the other two.
So the vaccine will play a significant role in tackling the pandemic, if it is approved for use by regulators.
"The announcement today takes us another step closer to the time when we can use vaccines to bring an end to the devastation caused by [the virus]," said the vaccine's architect, Prof Sarah Gilbert.
The UK government has pre-ordered 100 million doses of the Oxford vaccine, and AstraZeneca says it will make three billion doses for the world next year.
Prime Minister Boris Johnson said it was "incredibly exciting news" and that while there were still safety checks to come, "these are fantastic results".
continued at:
https://www.bbc.com/news/health-55040635
The coronavirus vaccine developed by the University of Oxford is highly effective at stopping people developing Covid-19 symptoms, a large trial shows.
Interim data suggests 70% protection, but the researchers say the figure may be as high as 90% by tweaking the dose.
The results will be seen as a triumph, but come after Pfizer and Moderna vaccines showed 95% protection.
However, the Oxford jab is far cheaper, and is easier to store and get to every corner of the world than the other two.
So the vaccine will play a significant role in tackling the pandemic, if it is approved for use by regulators.
"The announcement today takes us another step closer to the time when we can use vaccines to bring an end to the devastation caused by [the virus]," said the vaccine's architect, Prof Sarah Gilbert.
The UK government has pre-ordered 100 million doses of the Oxford vaccine, and AstraZeneca says it will make three billion doses for the world next year.
Prime Minister Boris Johnson said it was "incredibly exciting news" and that while there were still safety checks to come, "these are fantastic results".
continued at:
https://www.bbc.com/news/health-55040635
"Moderna Covid vaccine has 94% efficacy, final results confirm
https://www.theguardian.com/world/2...vaccine-has-94-efficacy-final-results-confirm
https://www.theguardian.com/world/2...vaccine-has-94-efficacy-final-results-confirm
